Computer Aided Drug Design: Success and Limitations.

By Mohd Hassan Baig, Khurshid Ahmad, Sudeep Roy, J. M. Ashraf, Mohd Adil, M. H. Siddiqui, Saif Khan, M. Kamal, I. Provazník, I. Choi. Current pharmaceutical design, 2016

350 citations recorded by the source corpus.

Subfields: Computational Theory and Mathematics, Molecular Biology, Organic Chemistry

View Paper: https://www.semanticscholar.org/paper/57b72ccdc19090ca9517e0104880d55d5b32b332

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Computational Theory and Mathematics

1. Gisbert Schneider
2. Petra Schneider
3. Matthias Zentgraf
4. W. Patrick Walters
5. Kimito Funatsu
6. Jennifer Listgarten
7. Johanna M. Jansen
8. Thomas Rush III

In Molecular Biology

1. Gisbert Schneider
2. Petra Schneider
3. W. Patrick Walters
4. Jennifer Listgarten
5. Shuguang Yuan
6. H. C. Stephen Chan
7. Zhenquan Hu
8. Roderick E. Hubbard

In Organic Chemistry

1. Petra Schneider
2. Gisbert Schneider
3. W. Patrick Walters

Citations in the corpus

• Rethinking drug design in the artificial intelligence era (2019, background): “In this context, computer-assisted small-molecule drug design has long been considered a potential opportunity 3–6 .”
• Using PyMOL as a platform for computational drug design (2017, methodology): “Nowadays, this process usually relies heavily on the computer visualization and modeling, and is therefore known as the computer-aided drug design (CADD).(6) CADD involves small *Correspondence to: shuguang.”